188 related articles for article (PubMed ID: 28493600)
1. Endurance training selectively increases high-density lipoprotein-bound sphingosine-1-phosphate in the plasma.
Książek M; Charmas M; Klusiewicz A; Zabielski P; Długołęcka B; Chabowski A; Baranowski M
Scand J Med Sci Sports; 2018 Jan; 28(1):57-64. PubMed ID: 28493600
[TBL] [Abstract][Full Text] [Related]
2. Exercise increases plasma levels of sphingoid base-1 phosphates in humans.
Baranowski M; Charmas M; Długołęcka B; Górski J
Acta Physiol (Oxf); 2011 Nov; 203(3):373-80. PubMed ID: 21535416
[TBL] [Abstract][Full Text] [Related]
3. Arteriovenous Sphingosine-1-Phosphate Differences Across Selected Organs of the Rat.
Książek M; Baranowska U; Chabowski A; Baranowski M
Cell Physiol Biochem; 2018; 45(1):67-77. PubMed ID: 29316552
[TBL] [Abstract][Full Text] [Related]
4. Elevating Endogenous Sphingosine-1-Phosphate (S1P) Levels Improves Endothelial Function and Ameliorates Atherosclerosis in Low Density Lipoprotein Receptor-Deficient (LDL-R-/-) Mice.
Feuerborn R; Besser M; Potì F; Burkhardt R; Weißen-Plenz G; Ceglarek U; Simoni M; Proia RL; Freise H; Nofer JR
Thromb Haemost; 2018 Aug; 118(8):1470-1480. PubMed ID: 30060257
[TBL] [Abstract][Full Text] [Related]
5. [Measurement of sphingosine 1-phosphate as a biomarker of atherosclerosis].
Kimura T; Okajima F; Murakami M
Rinsho Byori; 2007 Apr; 55(4):358-62. PubMed ID: 17511266
[TBL] [Abstract][Full Text] [Related]
6. Dihydro-sphingosine 1-phosphate interacts with carrier proteins in a manner distinct from that of sphingosine 1-phosphate.
Mishima Y; Kurano M; Kobayashi T; Nishikawa M; Ohkawa R; Tozuka M; Yatomi Y
Biosci Rep; 2018 Oct; 38(5):. PubMed ID: 30279204
[TBL] [Abstract][Full Text] [Related]
7. Correlation of high density lipoprotein (HDL)-associated sphingosine 1-phosphate with serum levels of HDL-cholesterol and apolipoproteins.
Zhang B; Tomura H; Kuwabara A; Kimura T; Miura S; Noda K; Okajima F; Saku K
Atherosclerosis; 2005 Jan; 178(1):199-205. PubMed ID: 15585219
[TBL] [Abstract][Full Text] [Related]
8. Erythrocytes increase endogenous sphingosine 1-phosphate levels as an adaptive response to SARS-CoV-2 infection.
Winkler MS; Claus RA; Schilder M; Pöhlmann S; Coldewey SM; Grundmann J; Fricke T; Moerer O; Meissner K; Bauer M; Hofmann-Winkler H; Gräler MH
Clin Sci (Lond); 2021 Dec; 135(24):2781-2791. PubMed ID: 34878105
[TBL] [Abstract][Full Text] [Related]
9. Sources, metabolism, and regulation of circulating sphingosine-1-phosphate.
Książek M; Chacińska M; Chabowski A; Baranowski M
J Lipid Res; 2015 Jul; 56(7):1271-81. PubMed ID: 26014962
[TBL] [Abstract][Full Text] [Related]
10. Quantification of sphingosine 1-phosphate by validated LC-MS/MS method revealing strong correlation with apolipoprotein M in plasma but not in serum due to platelet activation during blood coagulation.
Frej C; Andersson A; Larsson B; Guo LJ; Norström E; Happonen KE; Dahlbäck B
Anal Bioanal Chem; 2015 Nov; 407(28):8533-42. PubMed ID: 26377937
[TBL] [Abstract][Full Text] [Related]
11. Sphingosine 1-phosphate levels in plasma and HDL are altered in coronary artery disease.
Sattler KJ; Elbasan S; Keul P; Elter-Schulz M; Bode C; Gräler MH; Bröcker-Preuss M; Budde T; Erbel R; Heusch G; Levkau B
Basic Res Cardiol; 2010 Nov; 105(6):821-32. PubMed ID: 20652276
[TBL] [Abstract][Full Text] [Related]
12. Sphingosine-1-phosphate in acute exercise and training.
Hodun K; Chabowski A; Baranowski M
Scand J Med Sci Sports; 2021 May; 31(5):945-955. PubMed ID: 33345415
[TBL] [Abstract][Full Text] [Related]
13. High-Density Lipoprotein-Associated Apolipoprotein M Limits Endothelial Inflammation by Delivering Sphingosine-1-Phosphate to the Sphingosine-1-Phosphate Receptor 1.
Ruiz M; Frej C; Holmér A; Guo LJ; Tran S; Dahlbäck B
Arterioscler Thromb Vasc Biol; 2017 Jan; 37(1):118-129. PubMed ID: 27879252
[TBL] [Abstract][Full Text] [Related]
14. Defects of High-Density Lipoproteins in Coronary Artery Disease Caused by Low Sphingosine-1-Phosphate Content: Correction by Sphingosine-1-Phosphate-Loading.
Sattler K; Gräler M; Keul P; Weske S; Reimann CM; Jindrová H; Kleinbongard P; Sabbadini R; Bröcker-Preuss M; Erbel R; Heusch G; Levkau B
J Am Coll Cardiol; 2015 Sep; 66(13):1470-85. PubMed ID: 26403344
[TBL] [Abstract][Full Text] [Related]
15. Sphingosine 1-Phosphate Produced by Sphingosine Kinase 2 Intrinsically Controls Platelet Aggregation In Vitro and In Vivo.
Urtz N; Gaertner F; von Bruehl ML; Chandraratne S; Rahimi F; Zhang L; Orban M; Barocke V; Beil J; Schubert I; Lorenz M; Legate KR; Huwiler A; Pfeilschifter JM; Beerli C; Ledieu D; Persohn E; Billich A; Baumruker T; Mederos y Schnitzler M; Massberg S
Circ Res; 2015 Jul; 117(4):376-87. PubMed ID: 26129975
[TBL] [Abstract][Full Text] [Related]
16. Exercise increases sphingoid base-1-phosphate levels in human blood and skeletal muscle in a time- and intensity-dependent manner.
Baranowski M; Błachnio-Zabielska AU; Charmas M; Helge JW; Dela F; Książek M; Długołęcka B; Klusiewicz A; Chabowski A; Górski J
Eur J Appl Physiol; 2015 May; 115(5):993-1003. PubMed ID: 25519954
[TBL] [Abstract][Full Text] [Related]
17. Atheroprotective role of high-density lipoprotein (HDL)-associated sphingosine-1-phosphate (S1P).
Potì F; Simoni M; Nofer JR
Cardiovasc Res; 2014 Aug; 103(3):395-404. PubMed ID: 24891400
[TBL] [Abstract][Full Text] [Related]
18. Sustained decrease in plasma sphingosine-1-phosphate concentration and its accumulation in blood cells in acute myocardial infarction.
Knapp M; Lisowska A; Zabielski P; Musiał W; Baranowski M
Prostaglandins Other Lipid Mediat; 2013 Oct; 106():53-61. PubMed ID: 24120760
[TBL] [Abstract][Full Text] [Related]
19. Vehicle-dependent Effects of Sphingosine 1-phosphate on Plasminogen Activator Inhibitor-1 Expression.
Takahashi C; Kurano M; Nishikawa M; Kano K; Dohi T; Miyauchi K; Daida H; Shimizu T; Aoki J; Yatomi Y
J Atheroscler Thromb; 2017 Sep; 24(9):954-969. PubMed ID: 28321011
[TBL] [Abstract][Full Text] [Related]
20. High-density lipoprotein from end-stage renal disease patients exhibits superior cardioprotection and increase in sphingosine-1-phosphate.
Brinck JW; Thomas A; Brulhart-Meynet MC; Lauer E; Frej C; Dahlbäck B; Stenvinkel P; James RW; Frias MA
Eur J Clin Invest; 2018 Feb; 48(2):. PubMed ID: 29178180
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
